Arcturus Therapeutics: Q2 Earnings Snapshot
In this article:
SAN DIEGO (AP) — SAN DIEGO (AP) — Arcturus Therapeutics (ARCT) on Monday reported a loss of $52.6 million in its second quarter.
On a per-share basis, the San Diego-based company said it had a loss of $1.98.
The pharmaceutical company posted revenue of $10.5 million in the period.
Arcturus Therapeutics shares have climbed 88% since the beginning of the year. In the final minutes of trading on Monday, shares hit $31.85, a rise of 44% in the last 12 months.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ARCT at https://www.zacks.com/ap/ARCT
